Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 4/20 | 0.42 |
| ▸ | SI | P14410 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | G6PD | P11413 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27108742 | 0.86 | L3MBTL1 (0.49) | L3MBTL1LGALS8MAPTGAAPOLB | |
| SCHEMBL10137092 | 0.84 | L3MBTL1 (0.51) | L3MBTL1MAPTGAAPOLB | |
| SCHEMBL20990309 | 0.84 | L3MBTL1 (0.51) | L3MBTL1MAPTGAAPOLB | |
| SCHEMBL10082958 | 0.84 | L3MBTL1 (0.51) | L3MBTL1MAPTGAAPOLB | |
| SCHEMBL23636215 | 0.82 | L3MBTL1 (0.40) | L3MBTL1LGALS8MAPTMGAMSI | |
| SCHEMBL23810861 | 0.81 | MAPT (0.44) | L3MBTL1LGALS8MAPTGAAPOLB | |
| SCHEMBL13756825 | 0.81 | LGALS8 (0.56) | L3MBTL1LGALS8MAPTMGAMSI | |
| SCHEMBL7098842 | 0.81 | LGALS8 (0.56) | L3MBTL1LGALS8MAPTMGAMSI | |
| SCHEMBL24872329 | 0.81 | LGALS8 (0.56) | L3MBTL1LGALS8MAPTMGAMSI | |
| SCHEMBL22251726 | 0.81 | LGALS8 (0.56) | L3MBTL1LGALS8MAPTMGAMSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9458186-B2 | Polysaccharide derivative, method for producing the same, and separating agent | DAICEL CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20130116418-A1 | POLYSACCHARIDE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND SEPARATING AGENT | DAICEL CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116418-A1 | POLYSACCHARIDE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND SEPARATING AGENT | CSGALNACT1, ALG1, FUT5 | L3MBTL1 4642/4885LGALS8 746/4885MAPT 4177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.